Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges

被引：11

作者：

Blumer, Ian ^{[1
,2
]}

Clement, Maureen ^{[3
]}

机构：

[1] Charles H Best Diabet Ctr, Ajax, ON, Canada

[2] Univ Toronto, Dept Med, Toronto, ON, Canada

[3] Univ British Columbia, Diabet Educ Ctr, Vernon, BC, Canada

来源：

CLINICAL THERAPEUTICS | 2017年 / 39卷 / 08期

关键词：

basal insulin; hypoglycemia; management; type; 2; diabetes; TO-TARGET TRIAL; PATIENT-REPORTED OUTCOMES; GLARGINE; 100; UNITS/ML; GLYCEMIC CONTROL; COGNITIVE FUNCTION; GLUCOSE CONTROL; NPH INSULIN; PEOPLE; DEGLUDEC; RISK;

D O I：

10.1016/j.clinthera.2016.09.020

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Hypoglycemia in people with insulin-treated type 2 diabetes can be a limiting factor for management and a barrier to optimizing glycemic control. Even mild episodes of hypoglycemia can affect an individual's quality of life, and fear of hypoglycemia can lead to underinsulinization. This article explores the prevalence and consequences of hypoglycemia in people with type 2 diabetes with a focus on those who use basal insulins, offering strategies for prevention and management. It also discusses the benefits and challenges associated with new basal insulins, and their potential role in reducing hypoglycemia risk. (C) 2017 Elsevier HS Journals, Inc. All rights reserved.

引用

页码：S1 / S11

页数：11

共 50 条

[31] Predictors of HbA1c reduction and hypoglycemia in type 2 diabetes mellitus individuals switching from premixed to basal insulin: an exploratory analysis of optimization study
Yang, Wenying
Du, Juan
Zhang, Minlu
Hou, Jing
Zhang, Xia
Cui, Nan
CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (11) : 1807 - 1814
[32] Real-World Effects of Second-Generation Versus Earlier Intermediate/Basal Insulin Analogues on Rates of Hypoglycemia in Adults with Type 1 and 2 Diabetes (iNPHORM, US)
Black, Jason E.
Harris, Stewart B.
Ryan, Bridget L.
Zou, Guangyong
Ratzki-Leewing, Alexandria
DIABETES THERAPY, 2023, 14 (08) : 1299 - 1317
[33] Clinical Benefit of Insulin Glargine 300 U/mL Among Patients with Type 2 Diabetes Mellitus Previously Uncontrolled on Basal or Premixed Insulin in Serbia: A Prospective, Observational, Single-Arm, Multicenter, Real-World Study
Velojic-Golubovic, Milena
Ciric, Vojislav
Dimitrijevic, Marija
Kovic, Tijana
Mitic, Milica
Olujic, Biljana
Pevac, Natasa
Radenkovic, Sasa
Radojkovic, Danijela
Vukadinovic, Selena
Popovic, Djordje S.
DIABETES THERAPY, 2021, 12 (07) : 2049 - 2058
[34] New Insulins for Type 1 Diabetes treatment
Carmi, Hana Karime Rumie
Dominguez-Menendez, Gonzalo
Araya, Manuel
Martinez-Aguayo, Alejandro
ANDES PEDIATRICA, 2023, 94 (03): : 278 - 285
[35] Insulin Therapy in Type 2 Diabetes
Aschner, Pablo
AMERICAN JOURNAL OF THERAPEUTICS, 2020, 27 (01) : E79 - E90
[36] Management of hypoglycemia in older adults with type 2 diabetes
Freeman, Jeffrey
POSTGRADUATE MEDICINE, 2019, 131 (04) : 241 - 250
[37] Clinical and Cost Implications of Insulin Degludec in Patients with Type 1 Diabetes and Problematic Hypoglycemia: A Quality Improvement Project
Karamat, Muhammad Ali
Dar, Shujah
Bellary, Srikanth
Tahrani, Abd A.
DIABETES THERAPY, 2018, 9 (02) : 839 - 849
[38] Advances in newer basal and bolus insulins: impact on type 1 diabetes
Vliebergh, Joke
Lefever, Eveline
Mathieu, Chantal
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2021, 28 (01) : 1 - 7
[39] Current State and Principles of Basal Insulin Therapy in Type 2 Diabetes
Vargas-Uricoechea, Hernando
JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2022, 14 (01): : 8 - 21
[40] Addition of Basal Insulin to Oral Antidiabetic Agents in Patients with Inadequately Controlled Type 2 Diabetes Leads to Improved HbA1c Levels: Metabolic Control, Frequency of Hypoglycemia, and Insulin Titration Analysis as Results of a Prospective Observational Study (BALI Study)
Broz, Jan
Zdarska, Denisa Janickova
Stepanova, Radka
Kvapil, Milan
DIABETES THERAPY, 2019, 10 (02) : 663 - 672

← 1 2 3 4 5 →